Reply to Gatti and Pea, "Are the pharmacokinetic data of meropenem studied in CSF of a mixed population composed of patients with cerebral infections and patients with extracerebral infections really helpful for clinicians treating CNS infections?".
作者信息
Wicha Sebastian G, Kinast Christina, Münchow Max, Wittova Sandra, Greppmair Sebastian, Kunzelmann Alexandra K, Zoller Michael, Paal Michael, Vogeser Michael, Habler Katharina, Weig Thomas, Terpolilli Nicole, Heck Suzette, Dimitriadis Konstantinos, Scharf Christina, Liebchen Uwe
机构信息
Department of Clinical Pharmacy, Institute of Pharmacy, University of Hamburg, Hamburg, Germany.
Department of Anaesthesiology, LMU University Hospital, LMU Munich, Munich, Germany.
出版信息
Antimicrob Agents Chemother. 2024 Dec 5;68(12):e0146824. doi: 10.1128/aac.01468-24. Epub 2024 Nov 6.
Abstract
摘要
相似文献
1
Reply to Gatti and Pea, "Are the pharmacokinetic data of meropenem studied in CSF of a mixed population composed of patients with cerebral infections and patients with extracerebral infections really helpful for clinicians treating CNS infections?".
Antimicrob Agents Chemother. 2024 Dec 5;68(12):e0146824. doi: 10.1128/aac.01468-24. Epub 2024 Nov 6.
2
Are the pharmacokinetic data of meropenem studied in CSF of a mixed population composed of patients with cerebral infections and patients with extracerebral infections really helpful for clinicians treating CNS infections?
Antimicrob Agents Chemother. 2024 Dec 5;68(12):e0145324. doi: 10.1128/aac.01453-24. Epub 2024 Nov 6.
3
Meropenem pharmacokinetics in cerebrospinal fluid: comparing intermittent and continuous infusion strategies in critically ill patients-a prospective cohort study.
Antimicrob Agents Chemother. 2024 Sep 4;68(9):e0045124. doi: 10.1128/aac.00451-24. Epub 2024 Jul 31.
4
Meropenem concentrations in brain tissue of neurointensive care patients exceed CSF levels.
J Antimicrob Chemother. 2021 Oct 11;76(11):2914-2922. doi: 10.1093/jac/dkab286.
5
Plasma and cerebrospinal fluid population pharmacokinetic modeling and simulation of meropenem after intravenous and intrathecal administration in postoperative neurosurgical patients.
Diagn Microbiol Infect Dis. 2019 Apr;93(4):386-392. doi: 10.1016/j.diagmicrobio.2018.08.003. Epub 2018 Aug 17.
6
Population Pharmacokinetics of Combined Intravenous and Local Intrathecal Administration of Meropenem in Aneurysm Patients with Suspected Intracranial Infections After Craniotomy.
Eur J Drug Metab Pharmacokinet. 2018 Feb;43(1):45-53. doi: 10.1007/s13318-017-0422-1.
7
Pharmacodynamics of ceftazidime and meropenem in cerebrospinal fluid: results of population pharmacokinetic modelling and Monte Carlo simulation.
J Antimicrob Chemother. 2007 Nov;60(5):1038-44. doi: 10.1093/jac/dkm325. Epub 2007 Sep 4.
8
Cerebrospinal fluid penetration of meropenem in neurocritical care patients with proven or suspected ventriculitis: a prospective observational study.
Crit Care. 2016 Oct 24;20(1):343. doi: 10.1186/s13054-016-1523-y.
9
[Evaluation of the Bio-Speedy Meningitis/Encephalitis Panel in the Diagnosis of Central Nervous System Infections].
Mikrobiyol Bul. 2024 Jul;58(3):270-283. doi: 10.5578/mb.202497189.
10
Cerebrospinal pharmacokinetic and pharmacodynamic analysis of efficacy of meropenem in paediatric patients with bacterial meningitis.
Int J Antimicrob Agents. 2019 Sep;54(3):292-300. doi: 10.1016/j.ijantimicag.2019.06.021. Epub 2019 Jul 3.
本文引用的文献
1
Meropenem pharmacokinetics in cerebrospinal fluid: comparing intermittent and continuous infusion strategies in critically ill patients-a prospective cohort study.
Antimicrob Agents Chemother. 2024 Sep 4;68(9):e0045124. doi: 10.1128/aac.00451-24. Epub 2024 Jul 31.
2
A dosing nomograph for cerebrospinal fluid penetration of meropenem applied by continuous infusion in patients with nosocomial ventriculitis.
Clin Microbiol Infect. 2022 Jul;28(7):1022.e9-1022.e16. doi: 10.1016/j.cmi.2022.02.017. Epub 2022 Feb 17.
Zotero 插件